









市場行情
/
股票
/
nasdaq-osur
/

OraSure Technologies Inc

OSUR

2.400USD

-0.170-6.61%

收盤 11/06, 16:00（美東）報價延遲15分鐘

173.44M總市值

虧損本益比TTM



OraSure Technologies Inc

2.400

-0.170-6.61%

概覽公司財務分析

概覽

公司

財務

分析

關於 OraSure Technologies Inc 公司

OraSure Technologies, Inc. 提供即時診斷和家庭診斷測試、樣本管理解決方案以及微生物組實驗室和分析服務。該公司的產品組合分爲診斷產品和樣本管理解決方案。其業務包括開發、製造、營銷和銷售使用其技術的診斷產品和標本收集設備，以及其他診斷產品，包括用於其他標本類型的免疫測定和其他體外診斷測試。其診斷產品包括在即時診斷快速進行的 COVID-19、HIV 和丙型肝炎等疾病測試，以及在實驗室處理的濫用藥物測試。其業務還包括臨牀實驗室、直接面向消費者的實驗室、研究人員、製藥公司以及動物健康服務和產品提供商使用的分子樣本管理解決方案和服務。

OraSure Technologies Inc簡介



公司代碼OSUR

公司名稱OraSure Technologies Inc

上市日期Nov 17, 1986

CEOMs. Carrie Eglinton Manner

員工數量501

證券類型Ordinary Share

年結日Nov 17

公司地址220 E First St

城市BETHLEHEM

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編18015

電話15036416115

網址https://www.orasure.com/

公司代碼OSUR

上市日期Nov 17, 1986

CEOMs. Carrie Eglinton Manner

OraSure Technologies Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

448.46K

-2.72%

Dr. Nancy J. Gagliano, M.D.

Independent Director

158.15K

+72.80%

Mr. John P. Kenny

Independent Chairman of the Board

153.32K

+4.16%

Mr. Lelio Marmora

Independent Director

130.76K

+93.09%

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+109.45%

Ms. Anne Messing

Chief Commercial Officer

Mr. Steven Boyd ,

Independent Director

Mr. Robert W. Mcmahon

Independent Director

Mr. Jason Plagman

Vice President - Investor Relations

Ms. Carrie Eglinton Manner

President, Chief Executive Officer, Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Kenneth J. (Ken) Mcgrath

Chief Financial Officer

448.46K

-2.72%

Dr. Nancy J. Gagliano, M.D.

Independent Director

158.15K

+72.80%

Mr. John P. Kenny

Independent Chairman of the Board

153.32K

+4.16%

Mr. Lelio Marmora

Independent Director

130.76K

+93.09%

Hon Dr. David J. Shulkin, M.D.

Independent Director

126.33K

+109.45%

Ms. Anne Messing

Chief Commercial Officer

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Net product and services revenues - COVID-19

14.40M

46.09%

Net product and services revenues - HIV

9.86M

31.54%

Net product and service revenues -Molecular Products

4.13M

13.21%

Other revenues - Other non Product revenues

1.40M

4.47%

Net product and services revenues - Risk assessment testing

994.00K

3.18%

其他

474.00K

1.52%

地區USD

名稱

營收

佔比

United States

19.85M

63.54%

Africa (Region)

8.03M

25.69%

Europe

2.12M

6.78%

Other Regions

1.25M

3.99%

業務

地區

業務USD

名稱

營收

佔比

Net product and services revenues - COVID-19

14.40M

46.09%

Net product and services revenues - HIV

9.86M

31.54%

Net product and service revenues -Molecular Products

4.13M

13.21%

Other revenues - Other non Product revenues

1.40M

4.47%

Net product and services revenues - Risk assessment testing

994.00K

3.18%

其他

474.00K

1.52%

股東統計

更新時間: 8月19日週二

持股股東

股東類型

持股股東

佔比

Private Management Group, Inc.

7.61%

BlackRock Institutional Trust Company, N.A.

7.58%

The Vanguard Group, Inc.

5.81%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.23%

其他

67.98%

持股股東

佔比

Private Management Group, Inc.

7.61%

BlackRock Institutional Trust Company, N.A.

7.58%

The Vanguard Group, Inc.

5.81%

Neuberger Berman, LLC

5.79%

Altai Capital Management, L.P.

5.23%

其他

67.98%

股東類型

持股股東

佔比

Investment Advisor

40.12%

Investment Advisor/Hedge Fund

27.45%

Hedge Fund

21.36%

Individual Investor

5.12%

Research Firm

2.35%

Pension Fund

0.44%

Bank and Trust

0.30%

Venture Capital

0.09%

Insurance Company

0.04%

其他

2.73%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

451

67.31M

92.04%

-15.49M

2025Q2

473

72.08M

98.55%

-16.70M

2025Q1

483

70.23M

93.78%

-12.52M

2024Q4

475

70.81M

94.94%

-10.37M

2024Q3

471

70.30M

94.28%

-10.80M

2024Q2

477

73.05M

98.74%

-8.54M

2024Q1

473

74.45M

97.36%

-5.59M

2023Q4

464

73.29M

99.74%

-5.62M

2023Q3

456

72.50M

98.73%

-4.51M

2023Q2

452

70.73M

96.51%

-2.77M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Private Management Group, Inc.

5.46M

7.47%

+1.04M

+23.64%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.43M

7.43%

-141.00K

-2.53%

Jun 30, 2025

The Vanguard Group, Inc.

4.17M

5.7%

-120.08K

-2.80%

Jun 30, 2025

Neuberger Berman, LLC

4.16M

5.68%

-124.14K

-2.90%

Jun 30, 2025

Altai Capital Management, L.P.

3.75M

5.13%

+1.59M

+73.37%

Sep 02, 2025

Dimensional Fund Advisors, L.P.

3.84M

5.25%

+14.96K

+0.39%

Jun 30, 2025

Renaissance Technologies LLC

2.28M

3.11%

-294.84K

-11.47%

Jun 30, 2025

Systematic Financial Management, L.P.

2.23M

3.05%

+581.93K

+35.33%

Jun 30, 2025

Acadian Asset Management LLC

2.19M

-563.24K

-20.44%

Jun 30, 2025

American Century Investment Management, Inc.

2.08M

2.85%

-423.60K

-16.91%

Jun 30, 2025

持股ETF



更新時間: 22 小時前

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.47%

iShares US Small Cap Value Factor ETF

0.38%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.07%

iShares Micro-Cap ETF

0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.05%

Avantis US Small Cap Equity ETF

0.03%

WisdomTree US SmallCap Fund

0.03%

iShares US Small-Cap Equity Factor ETF

0.02%

iShares Russell 2000 Value ETF

0.02%

ProShares UltraPro Russell2000

0.01%

Invesco NASDAQ Future Gen 200 ETF

佔比0.47%

iShares US Small Cap Value Factor ETF

佔比0.38%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

佔比0.07%

iShares Micro-Cap ETF

佔比0.05%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.05%

Avantis US Small Cap Equity ETF

佔比0.03%

WisdomTree US SmallCap Fund

佔比0.03%

iShares US Small-Cap Equity Factor ETF

佔比0.02%

iShares Russell 2000 Value ETF

佔比0.02%

ProShares UltraPro Russell2000

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

KeyAI

